IV 

House Calendar No. 133 

115TH CONGRESS 

2D SESSION H. RES. 787 

[Report No. 115–613] 

Providing for consideration of the bill (H.R. 4566) to amend the DoddFrank Wall Street Reform and Consumer Protection Act to provide 

relief to nonbanks from certain stress test requirements under such 

Act; providing for consideration of the bill (H.R. 5247) to authorize 

the use of eligible investigational drugs by eligible patients who have 

been diagnosed with a stage of a disease or condition in which there 

is reasonable likelihood that death will occur within a matter of months, 

or with another eligible illness, and for other purposes; and for other 

purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 19, 2018 

Mr. BURGESS, from the Committee on Rules, reported the following resolution; which was referred to the House Calendar and ordered to be printed 

RESOLUTION 

Providing for consideration of the bill (H.R. 4566) to amend 

the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain 

stress test requirements under such Act; providing for 

consideration of the bill (H.R. 5247) to authorize the 

use of eligible investigational drugs by eligible patients 

who have been diagnosed with a stage of a disease or 

condition in which there is reasonable likelihood that 


pbinns on DSK79D2C42PROD with BILLS
2 

•HRES 787 RH 

death will occur within a matter of months, or with 

another eligible illness, and for other purposes; and for 

other purposes. 

1 Resolved, That upon adoption of this resolution it 

2 shall be in order to consider in the House the bill (H.R. 

3 4566) to amend the Dodd-Frank Wall Street Reform and 

4 Consumer Protection Act to provide relief to nonbanks 

5 from certain stress test requirements under such Act. All 

6 points of order against consideration of the bill are waived. 

7 In lieu of the amendment in the nature of a substitute 

8 recommended by the Committee on Financial Services now 

9 printed in the bill, an amendment in the nature of a sub10 stitute consisting of the text of Rules Committee Print 

11 115-65 shall be considered as adopted. The bill, as amend12 ed, shall be considered as read. All points of order against 

13 provisions in the bill, as amended, are waived. The pre14 vious question shall be considered as ordered on the bill, 

15 as amended, and on any further amendment thereto, to 

16 final passage without intervening motion except: (1) one 

17 hour of debate equally divided and controlled by the chair 

18 and ranking minority member of the Committee on Finan19 cial Services; (2) the further amendment printed in the 

20 report of the Committee on Rules accompanying this reso21 lution, if offered by the Member designated in the report, 

22 which shall be in order without intervention of any point 

23 of order, shall be considered as read, shall be separately 


pbinns on DSK79D2C42PROD with BILLS
3 

•HRES 787 RH 

1 debatable for the time specified in the report equally di2 vided and controlled by the proponent and an opponent, 

3 and shall not be subject to a demand for a division of the 

4 question; and (3) one motion to recommit with or without 

5 instructions. 

6 SEC. 2. Upon adoption of this resolution it shall be 

7 in order to consider in the House the bill (H.R. 5247) 

8 to authorize the use of eligible investigational drugs by 

9 eligible patients who have been diagnosed with a stage of 

10 a disease or condition in which there is reasonable likeli11 hood that death will occur within a matter of months, or 

12 with another eligible illness, and for other purposes. All 

13 points of order against consideration of the bill are waived. 

14 The bill shall be considered as read. All points of order 

15 against provisions in the bill are waived. The previous 

16 question shall be considered as ordered on the bill and on 

17 any amendment thereto to final passage without inter18 vening motion except: (1) one hour of debate equally di19 vided and controlled by the chair and ranking minority 

20 member of the Committee on Energy and Commerce; and 

21 (2) one motion to recommit. 

22 SEC. 3. The requirement of clause 6(a) of rule XIII 

23 for a two-thirds vote to consider a report from the Com24 mittee on Rules on the same day it is presented to the 


pbinns on DSK79D2C42PROD with BILLS
4 

•HRES 787 RH 

1 House is waived with respect to any resolution reported 

2 through the legislative day of March 23, 2018. 

3 SEC. 4. It shall be in order at any time on the legisla4 tive day of March 22, 2018, or March 23, 2018, for the 

5 Speaker to entertain motions that the House suspend the 

6 rules as though under clause 1 of rule XV. The Speaker 

7 or his designee shall consult with the Minority Leader or 

8 her designee on the designation of any matter for consid9 eration pursuant to this section. 

10 SEC. 5. Section 3(a) of House Resolution 5 is amend11 ed by striking ′′the first session of′′. 


pbinns on DSK79D2C42PROD with BILLS

pbinns on DSK79D2C42PROD with BILLS
House Calendar No. 133 

115TH CONGRESS 

2D SESSION H. RES. 787 

[Report No. 115–613] 

RESOLUTION 

Providing for consideration of the bill (H.R. 4566) 

poses; and for other purposes. or with another eligible illness, and for other purthat death will occur within a matter of months, condition in which there is reasonable likelihood have been diagnosed with a stage of a disease or ble investigational drugs by eligible patients who the bill (H.R. 5247) to authorize the use of eligiunder such Act; providing for consideration of nonbanks from certain stress test requirements and Consumer Protection Act to provide relief to to amend the Dodd-Frank Wall Street Reform 

MARCH 19, 2018 

Referred to the House Calendar and ordered to be 

printed 


pbinns on DSK79D2C42PROD with BILLS